Genetic inhibitors of APOBEC3B-induced mutagenesis
Genome Research · 2023
DOI: 10.1101/gr.277430.122 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genome Research, 2023. Verfasst von Tony M Mertz und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Molecular Biosciences and Center for Reproductive Biology, Washington State University, Pullman, Washington 99164, USA; tony.mertz@wsu.edu …. Hauptthemen laut MEDLINE: BRCA1 Protein, Breast Neoplasms. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIEHS NIH HHS, NCI NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
The cytidine deaminases APOBEC3A (A3A) and APOBEC3B (A3B) are prominent mutators of human cancer genomes. However, tumor-specific genetic modulators of APOBEC-induced mutagenesis are poorly defined. Here, we used a screen to identify 61 gene deletions that increase A3B-induced mutations in yeast. We also determined whether each deletion was epistatic with Ung1 loss, which indicated whether the encoded factors participate in the homologous recombination (HR)–dependent bypass of A3B/Ung1-dependent abasic sites or suppress A3B-catalyzed deamination by protecting against aberrant formation of single-stranded DNA (ssDNA). We found that the mutation spectra of A3B-induced mutations revealed genotype-specific patterns of strand-specific ssDNA formation and nucleotide incorporation across APOBEC-induced lesions. Combining these three metrics, we were able to establish a multifactorial signature of APOBEC-induced mutations specific to (1) failure to remove H3K56 acetylation, (2) defective CTF18–RFC complex function, and (3) defective HR-mediated bypass of APOBEC-induced lesions. We extended these results by analyzing mutation data for human tumors and found BRCA1/2-deficient breast cancers display three- to fourfold more APOBEC-induced mutations. Mirroring our results in yeast, Rev1-mediated C-to-G substitutions are mainly responsible for increased APOBEC-signature mutations in BRCA1/2-deficient tumors, and these mutations associate with lagging strand synthesis during replication. These results identify important factors that influence DNA replication dynamics and likely the abundance of APOBEC-induced mutation during tumor progression. They also highlight a novel role for BRCA1/2 during HR-dependent lesion bypass of APOBEC-induced lesions during cancer cell replication.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Molecular Biosciences and Center for Reproductive Biology, Washington State University, Pullman, Washington 99164, USA; tony.mertz@wsu.edu steven.roberts2@wsu.edu srober23@uvm.edu.
- Department of Microbiology and Molecular Genetics, University of Vermont Cancer Center, University of Vermont, Burlington, Vermont 05405, USA.
- School of Molecular Biosciences and Center for Reproductive Biology, Washington State University, Pullman, Washington 99164, USA.
- School of Biological Sciences, Georgia Institute of Technology, Atlanta, Georgia 30332, USA.
Förderung
- NIEHS NIH HHS
- NCI NIH HHS
- NIGMS NIH HHS
- National Institutes of Health
- National Institute of Environmental Health Sciences
- National Cancer Institute
- Breast Cancer Research
- Department of Defense
Zitieren
APA
Mertz, T. M., Rice-Reynolds, E., Nguyen, L., Wood, A., Cordero, C., Bray, N., Harcy, V., Vyas, R. K., Mitchell, D., Lobachev, K., & Roberts, S. A. (2023). Genetic inhibitors of APOBEC3B-induced mutagenesis. Genome Research. https://doi.org/10.1101/gr.277430.122
Vancouver
Mertz TM, Rice-Reynolds E, Nguyen L, Wood A, Cordero C, Bray N, et al. Genetic inhibitors of APOBEC3B-induced mutagenesis. Genome Research. 2023. doi:10.1101/gr.277430.122
BibTeX
@article{Mertz2023,
author = {Mertz, Tony M and Rice-Reynolds, Elizabeth and Nguyen, Ly and Wood, Anna and Cordero, Cameron and Bray, Nicholas and Harcy, Victoria and Vyas, Rudri K and Mitchell, Debra and Lobachev, Kirill and Roberts, Steven A},
title = {Genetic inhibitors of APOBEC3B-induced mutagenesis},
journal = {Genome Research},
year = {2023},
doi = {10.1101/gr.277430.122}
}
EUVIMED